Probiotic Receipt and Neurodevelopmental Outcomes of Infants <29 Weeks' Gestation: A Cohort Study - 27/11/25
, Nicole Bando, PhD 1, Seungwoo Lee, MSc 1, Kamini Raghuram, MD, MSc 1, 2, Marc Beltempo, MD, MSc 3, 4, Carlos Fajardo, MD 5, Valérie Bertelle, MD 6, Linh G. Ly, MD 7, 2, Rudaina Banihani, MD 8, Belal N. Alshaikh, MD, MSc 5on behalf of the
Canadian Preterm Birth Network, Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators †
Abstract |
Objective |
To examine neurodevelopment and growth following probiotic receipt in neonatal intensive care units.
Study design |
A national, population-representative, multicenter, retrospective cohort study was conducted on children born at <29 weeks' gestation between January 1, 2014, and December 31, 2020, from 21 neonatal units in Canada who survived and then underwent follow-up between ages 18 and 30 months. Children who received vs did not receive probiotics were compared for the primary outcome of significant neurodevelopmental impairment, defined as any of the following: Bayley Scales of Infant and Toddler Development-III cognitive, language, or motor score <70; cerebral palsy with Gross Motor Function Classification System III-V; hearing aid or cochlear implant; or bilateral visual impairment. Equivalence analyses utilizing a 4% margin for outcomes between groups were conducted using logistic regression and propensity score-matched analyses to calculate adjusted risk difference (RD) and CIs.
Results |
A total of 2749 children in the probiotics group (median gestation 26 weeks and birth weight 920 grams) and 2442 in the no probiotics group (median gestation 26 weeks and birth weight 890 grams) were evaluated. Baseline characteristics were similar between groups. For the outcome of significant neurodevelopmental impairment, logistic regression analyses indicated that probiotics were equivalent to no probiotics (adjusted RD −0.23%, 95% CI: 2.61%, 2.15%), whereas propensity score-matched analyses (1474 pairs of children) indicated probiotics were nonequivalent and potentially superior (adjusted RD −4.01%, 95% CI: 6.92%, −1.01%). Results of the majority of secondary outcomes were similar, including growth outcomes.
Conclusions |
Probiotics were not associated with harm in neurodevelopment and growth of surviving preterm neonates and may be potentially superior to no probiotics for neurodevelopment and growth among surviving preterm neonates <29 weeks' gestation.
Le texte complet de cet article est disponible en PDF.Keywords : growth, neurodevelopment, preterm infant, probiotics
Abbreviations : Bayley, CNFUN, CNN, NDI, NEC, NICU, PS, RD, sNDI
Plan
Vol 287
Article 114783- décembre 2025 Retour au numéro
Article précédent
- Radiographic Severity of Neonatal Deep Medullary Venous Thrombosis is Associated with Neurodevelopmental Impairment
- Ria Pal, Gabrielle Russo Barsh, Ingrid Luo, Hisham Dahmoush, Sarah Lee, Elizabeth Mayne
- Head Growth in Infants with Benign Enlargement of Subarachnoid Spaces Versus Macrocephaly
- Sasidhar Karuparti, Ashlynn Lizer, Farrell Landwehr, Francisco Narro Garcia, Gabrielle Johnson, Gretchen Koller, Diane Aum, Ali Mian, Jennifer M. Strahle
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?